Fig. 3From: Cilostazol protects against degenerative cervical myelopathy injury and cell pyroptosis via TXNIP-NLRP3 pathwayEffects of Cilostazol on GAP-43 and Iba-1 expressions in DCM rats were detected by immunohistochemistry (Scar bar: 20 μm). A GAP-43 expressions; B Iba-1 expressions. *p < 0.05 vs. Sham group; #p < 0.05 vs. DCM group; &p < 0.05 vs. Cilostazol (15 mg/kg) groupBack to article page